These emerging treatments, Tirzepatide , represent a significant advancement in addressing obesity and conceivably associated ailments . These drugs are classified as GLP-1 pathway agonists , meaning they to replicate the body's GLP-1 peptide, enhancing glucose release and suppressing hunger . De